EWA
ARKG icon

Exencial Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Exencial Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,412
Closed -$213K – 486
2024
Q1 		$213K Buy
7,412
+276
+4% +$8.3K 0.01% 480
2023
Q4 		$234K Sell
7,136
-715
-9% -$19.4K 0.01% 453
2023
Q3 		$219K Sell
7,851
-7
-0.1% -$229 0.01% 402
2023
Q2 		$268K Sell
7,858
-2,407
-23% -$75.7K 0.01% 386
2023
Q1 		$309K Buy
10,265
+1,422
+16% +$44.1K 0.02% 349
2022
Q4 		$250K Sell
8,843
-428
-5% -$13.6K 0.01% 381
2022
Q3 		$305K Sell
9,271
-207
-2% -$7.6K 0.02% 340
2022
Q2 		$298K Sell
9,478
-171
-2% -$5.98K 0.02% 349
2022
Q1 		$443K Buy
9,649
+53
+0.6% +$2.53K 0.02% 300
2021
Q4 		$588K Buy
+9,596
New +$663K 0.03% 285
2021
Q3 		– Sell
-12,089
Closed -$1.12M – 330
2021
Q2 		$1.12M Hold
12,089
– – 0.06% 224
2021
Q1 		$1.07M Buy
12,089
+1,184
+11% +$117K 0.06% 211
2020
Q4 		$1.02M Buy
10,905
+2,075
+23% +$165K 0.07% 196
2020
Q3 		$563K Buy
8,830
+279
+3% +$16.3K 0.03% 246
2020
Q2 		$446K Buy
+8,551
New +$367K 0.04% 228

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Exencial Wealth Advisors's ARKG Position: Q2 2024 in Review

Exencial Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 7,412 shares — an estimated $213K sold.

Exencial Wealth Advisors first reported a position in ARKG in Q2 2020 and held it in 15 quarters. The position peaked at $1.12M in Q2 2021. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Exencial Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Exencial Wealth Advisors sold 7,412 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $213K.
  • Exencial Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 15 quarters.
  • Exencial Wealth Advisors's ARK Genomic Revolution ETF position peaked at $1.12M in Q2 2021.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Exencial Wealth Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.